Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.405 USD | -2.54% | +7.07% | -12.38% |
May. 30 | Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target | MT |
May. 16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.98% | 186M | |
+45.51% | 56.65B | |
-6.93% | 39.44B | |
+39.19% | 39.03B | |
-11.17% | 26.86B | |
+12.30% | 26.75B | |
-21.71% | 19.03B | |
+1.46% | 12.28B | |
+23.79% | 12.26B | |
+27.10% | 12.04B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Transcript : Abeona Therapeutics Inc., Q1 2021 Earnings Call, May 25, 2021